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Inhibitory glycine receptors (GlyRs) are pentameric ligand-gated anion channels with
major roles in startle disease/hyperekplexia (GlyR α1), cortical neuronal migration/autism
spectrum disorder (GlyR α2), and inflammatory pain sensitization/rhythmic breathing
(GlyR α3). However, the role of the GlyR α4 subunit has remained enigmatic, because the
corresponding human gene (GLRA4) is thought to be a pseudogene due to an in-frame
stop codon at position 390 within the fourth membrane-spanning domain (M4). Despite
this, a recent genetic study has implicated GLRA4 in intellectual disability, behavioral
problems and craniofacial anomalies. Analyzing data from sequenced genomes, we
found that GlyR α4 subunit genes are predicted to be intact and functional in the
majority of vertebrate species—with the exception of humans. Cloning of human GlyR
α4 cDNAs excluded alternative splicing and RNA editing as mechanisms for restoring
a full-length GlyR α4 subunit. Moreover, artificial restoration of the missing conserved
arginine (R390) in the human cDNA was not sufficient to restore GlyR α4 function. Further
bioinformatic and mutagenesis analysis revealed an additional damaging substitution at
K59 that ablates human GlyR α4 function, which is not present in other vertebrate GlyR
α4 sequences. The substitutions K59 and X390 were also present in the genome of
an ancient Denisovan individual, indicating that GLRA4 has been a pseudogene for at
least 30,000–50,000 years. In artificial synapses, we found that both mouse and gorilla
α4β GlyRs mediate synaptic currents with unusually slow decay kinetics. Lastly, to gain
insights into the biological role of GlyR α4 function, we studied the duplicated genes
glra4a and glra4b in zebrafish. While glra4b expression is restricted to the retina, using
a novel tol2-GAL4FF gene trap line (SAIGFF16B), we found that the zebrafish GlyR α4a
subunit gene (glra4a) is strongly expressed in spinal cord and hindbrain commissural
neurones. Using gene knockdown and a dominant-negative GlyR α4aR278Q mutant, we
found that GlyR α4a contributes to touch-evoked escape behaviors in zebrafish. Thus,
although GlyR α4 is unlikely to be involved in human startle responses or disease states,
this subtype may contribute to escape behaviors in other organisms.
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INTRODUCTION
Inhibitory glycine receptors (GlyRs) are ligand-gated anion
channels, consisting of pentameric combinations of GlyR α and
β subunits. There are five known GlyR subtypes (containing α1,
α2, α3 or α4 subunits together with the GlyR β subunit) that
are differentially expressed in developing brain and adult spinal
cord, hindbrain, cerebellum and retina. Mutations in GLRA1
and GLRB, encoding the GlyR α1 and β subunits, cause startle
disease/hyperekplexia, a neurological disorder characterized by
noise- or touch-induced seizures in neonates (Shiang et al., 1993;
Rees et al., 2002; Chung et al., 2010, 2013; James et al., 2013).
Allelic variants of GLRB may also contribute to the risk of panic
disorder by increasing startle responses and thus agoraphobic
cognitions (Deckert et al., 2017). However, the biological roles
of other GlyR subtypes, containing the α2, α3 and α4 subunits,
are still under investigation. Knockout mice have revealed roles
for GlyR α2 in retinal rod photoreceptor development, crossover
inhibition and the receptive field surround of ‘‘off’’ retinal
ganglion cells (Young and Cepko, 2004; Nobles et al., 2012;
Zhang C. et al., 2015). GlyR α2 also appears to modulate ethanol
consumption, since knockout mice show reduced ethanol intake
and preference in the two-bottle choice test (Blednov et al.,
2015). Most recently, GlyR α2 has been shown to control
cortical neuronal progenitor homeostasis, migration and circuit
formation (Avila et al., 2013, 2014; Morelli et al., 2017) with
mild microcephaly (Avila et al., 2014), susceptibility to seizures
(Morelli et al., 2017) and deficits in long-term potentiation and
object recognition memory (Pilorge et al., 2016) observed in
Glra2 knockout mice. Consistent with these findings, loss of
functionmutations in the human GlyR α2 subunit gene (GLRA2)
have been reported in cases of autism spectrum disorder, with
additional features in some cases such as language delay and
seizures (Pinto et al., 2010; Piton et al., 2011; Iossifov et al.,
2014; Pilorge et al., 2016). By contrast, the generation of GlyR
α3 subunit knockout mice and subtype specific antibodies
revealed that this subtype is abundant in the spinal cord dorsal
horn, where it plays a key role in central inflammatory pain
sensitization (Harvey et al., 2004, 2009; Hösl et al., 2006). This
has led to significant interest in GlyR α3 as a target for novel
analgesics (Harvey et al., 2004; Xiong et al., 2011; Balansa et al.,
2013; Han et al., 2013; Acuña et al., 2016; Stead et al., 2016;
Huang et al., 2017). However, it is important to note that GlyR
α3 also has other biological roles. For example, a 5-HTR1A-
GlyR α3 signaling pathway controls rhythmic breathing in the
brainstem pre-Bötzinger complex (Manzke et al., 2010), with
disruption of this pathway in GlyR α3 knockout mice resulting
in an irregular respiratory rhythm. GlyR α3 knockout mice
also show increased ethanol intake, preference and increased
development of conditioned taste aversion to ethanol (Blednov
et al., 2015). Lastly, GlyR α3 is involved in hearing, and has
important functions in auditory nerve activity (Dlugaiczyk et al.,
2016) and signal-in-noise detection (Tziridis et al., 2017).
By comparison, the GlyR α4 subtype is poorly studied,
largely because the human gene (GLRA4) is considered to be
a pseudogene (Simon et al., 2004) due to the presence of an
in-frame stop codon at position 390 (390X) in exon 9, truncating
the GlyR subunit within the fourth membrane-spanning domain
(M4). This often leads to the incorrect assumption that GLRA4
is not expressed in human brain (Bar-Shira et al., 2015) and is
therefore not biologically relevant. However, one mystery that
remains unexplained is why the GlyR α4 subunit gene appears
to be intact in all other species studied to date (Matzenbach et al.,
1994; Harvey et al., 2000) and is even duplicated (GlyR α4a and
α4b) in zebrafish (Imboden et al., 2001; Hirata et al., 2010). GlyR
α4 subunit expression has been detected by in situ hybridization
and PCR assays in chicken embryonic sympathetic neurons,
where depolarizing GlyRs have been linked to neurotransmitter
release (Boehm et al., 1997; Harvey et al., 2000). GlyR α4 was
also found in spinal cord white matter, dorsal root ganglia and
the male genital ridge in birds (Harvey et al., 2000). More
recently, the development of new subunit-specific antibodies
also allowed localization of GlyR α4 in cholinergic amacrine
cells in mouse retina (Heinze et al., 2007). Interest in GlyR
α4 has recently been rekindled by reports that GLRA4 in humans
is potentially involved in intellectual disability, behavioral
problems and craniofacial anomalies (Labonne et al., 2016). An
11-year-old female patient (DGDP084) with these symptoms
was reported to have a de novo Xq22.2 110 kb microdeletion
encompassing GLRA4, MORF4L2 and TCEAL. While certain
phenotypic features such as cognitive impairment and motor
delay overlap with Pelizaeus-Merzbacher disease (PMD) caused
by PLP1 mutations at Xq22.2, this gene was apparently not
included in the microdeletion and was not dysregulated by a
positional effect (Labonne et al., 2016). Since GlyR α4 transcripts
were reduced in the female patient compared to her healthy
mother, the authors suggested that loss of one allele of GLRA4
was a plausible explanation for the clinical symptoms observed
in this individual. However, in this study, we demonstrate that
although the human GlyR α4 subunit gene is expressed and
correctly spliced, multiple inactivating substitutions render the
human GlyR α4 subunit dysfunctional in modern and ancient
humans. We also investigate the physiological properties of
inhibitory synaptic currents mediated by α4β GlyRs in artificial
synapses. Finally, we report that the expression pattern and
knockdown of the zebrafish GlyR α4a subunit are consistent with
a role for the GlyR α4 subunit in mediating startle and escape
responses.
MATERIALS AND METHODS
Phylogenetic Analysis and Cloning of GlyR
α4 Subunit Sequences
The human GlyR α4 subunit was aligned with orthologs
predicted from Denisova, Neanderthal and other vertebrate
genomes obtained via Ensembl version 87 (Aken et al.,
2017) or the UCSC Genome Browser (Kent et al., 2002).
Alignments were made and edited using CLC Main Workbench
6 software. Positions of membrane-spanning domains and
other structural features were mapped based on the recent
cryo-EM structures of the zebrafish GlyR α1 subunit (3JAE;
Du et al., 2015). Human and mouse GlyR α4 subunit cDNAs
were amplified from whole-brain first-strand cDNA (Clontech,
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Cat. 637242 and 637301) using primers hGlyR α4-BamHI
5′-caaggatccgccaccatgacaactcttgttcctgc-3′/hGlyR α4-XhoI
5′-ccactcgagtcacagagcctggtggatatc-3′ or mGlyR α4-EcoRI 5′-
caagaattcgccaccatgacaactcttgttccagcaa-3′/mGlyR α4-SalI 5′-
ccagtcgactcacagtgcctggtggatatctt-3′, cloned into the expression
vector pRK5. Gorilla and Chimp GlyR α4 subunit cDNAs
were artificially synthesized from predicted cDNA sequences
(Gorilla: XM_004064625.1; Chimp: XM_009439421.2) and
recloned into pRK5 using the primers gGlyR α4EcoRI 5′-
caagaattcgccaccatgacaactcttgttcctgaaa-3′/gGlyR α4SalI and
5′-ccagtcgactcacagtgcctggtggatatctt-3′ and cGlyR α4-EcoRI
5′-caagaattcgccaccatgacaactcttgttcctgcaa-3′/cGlyR α4-SalI 5′-
cttgtcgactcacagagcctggtggatatctt-3′, respectively. In each case, an
optimized Kozak sequence was introduced upstream of the start
methionine (GCCACC in oligonucleotide sequences).
Site-Directed Mutagenesis and DNA
Sequencing
Sequence changes were introduced into pRK5-human GlyR
α4 and pRK5-mouse GlyR α4 using the QuikChange Lightning
site-directed mutagenesis kit (Agilent). All expression constructs
were confirmed by Sanger DNA sequencing of the entire
coding region and analyzed using Sequencher 4.10 (Gene Codes
Corporation). Sanger DNA sequencing was performed by DNA
Sequencing and Services (MRCPPU, College of Life Sciences,
University of Dundee, Scotland).
Primary Culture of Spinal Neurons
Spinal neurons were prepared using methods as recently
described (Dixon et al., 2015). Briefly, E15 timed-pregnant
rats were euthanized via CO2 inhalation in accordance with
procedures approved by the University of Queensland Animal
Ethics Committee. The spinal cords were rapidly removed,
triturated and plated onto poly-D-lysine-coated coverslips in a
4-well plate at a density of 8–10 × 104 cells/well, and cultured
for 3–4 weeks until spontaneous inhibitory postsynaptic currents
(IPSCs) could be detected. The cells were initially cultured in
Dulbecco’s Modified Eagles Medium (DMEM) supplemented
with 10% fetal bovine serum (DMEM-FBS). After 24 h the entire
DMEM-FBS medium was replaced with Neurobasal medium
including 2% B27 and 1% GlutaMAX supplements. A second
(and final) feed 1 week later replaced half of this medium with
fresh Neurobasal medium. Neurons were used in co-culture
experiments between 1–4 weeks later.
HEK293 Cell Culture, Transfection and
Artificial Synapse Formation
Artificial synapses were generated as previously described
(Zhang Y. et al., 2015). Briefly, HEK293 cells were cultured
in DMEM-FBS until ∼90% confluent. One day prior to
transfection, they were trypsinized and plated onto glass
coverslips in 35 mm culture dishes at a density of 5 × 103
cells/dish. Homomeric channels were transfected with 0.3 µg
of α4 subunit constructs (pRK5). Heteromeric channels were
transfected at a ratio of 1:50, with 0.02 µg GlyR α4 and
1 µg β subunit constructs (pRK5). 0.1 µg EGFP (pEGFP) was
used as a transfection marker. For artificial synapses, 0.3 µg
of mouse neuroligin 2A (pNice) and 0.3 µg of rat gephyrin
(pCIS) were also added. Transfection was performed via a
Ca2+ phosphate-DNA co-precipitation method for 15–20 h in
a 3% CO2 incubator and terminated by washing cells twice
with divalent cation-free phosphate buffered saline. Cells were
trypsinized the next day, centrifuged and re-suspended in
Neurobasal medium (including 2% B27 and 1% GlutaMAX
supplements) then seeded onto the neurons. One 35 mm dish
of HEK293 cells was typically sufficient to seed four coverslips
of neurons. Once seeded with HEK293 cells, the co-cultures
were returned to the incubator overnight to allow artificial
synapses to form between neurons and transfected HEK293 cells.
Cells were used for patch-clamp recording over the following
2–3 days.
Electrophysiology
Whole-cell patch clamp recordings were performed at room
temperature (22 ± 1◦C). Glycine concentration-response
relationships were performed at −40 mV, whereas artificial
synapse recordings were performed at −70 mV, both using a
Multiclamp 700B amplifier and pClamp10 software (Molecular
Devices). Signals were filtered at 4 kHz and sampled at 10 kHz.
Patch pipettes (4–8 MΩ resistance) were fabricated from
borosilicate glass (GC150F-7.5, Harvard Apparatus) and filled
with an internal solution comprising (in mM): 145 CsCl,
2 CaCl2, 2 MgCl2, 10 HEPES and 10 EGTA, adjusted to pH
7.4 with CsOH. The extracellular solution comprised (in mM)
140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES and 10 D-glucose,
adjusted to pH 7.4 with NaOH.
Outside-out macropatch recordings were performed at
−70 mV using an Axopatch 200B amplifier, pClamp 10 software,
filtered at 10 kHz and sampled at 50 kHz. Current traces were
filtered off-line at 5 kHz for making figures. Pipettes were
fire-polished to a resistance of ∼10 MΩ and filled with the same
internal solution. Outside-out patches pulled from transfected
HEK293 cells were activated by brief (<1ms) exposure to glycine
using a piezo-electric translator (Siskiyou). The speed of the
solution exchange system was regularly calibrated by rapidly
switching the solution perfusing an open patch pipette between
standard extracellular solution and an extracellular solution that
had been diluted by 50% with distilled water. By monitoring
the resulting pipette current, we were able to ensure that the
solution perfusing the macropatch was completely exchanged
within 200 µs (Dixon et al., 2014).
Data Analysis
Analyses of IPSC amplitudes, 10%–90% rise times, and decay
time constants were performed using Axograph X (Axograph
Scientific). Only cells with a stable series resistance of <25 MΩ
throughout the recording period were selected for analysis.
IPSCs were detected using a semi-automated sliding template.
Each detected event was visually inspected and only those with
no inflections in the rising or decay phases were included.
All selected events from a single cell were digitally averaged.
Parameters derived from these digitally averaged waveforms
were then pooled with those form other cells to obtain group
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data. To calculate macroscopic current decay time constants,
digitally averaged macroscopic recordings were fitted with
double-exponential functions in Axograph X, and a weighted
time constant was calculated from individual time constants
(τ1, τ2) and their relative amplitude (A1, A2) as follows:
τweighted = (τ1× A1 + τ2× A2)/(A1 + A2).
Displayed averaged data represent group means ± SEMs.
The Hill equation was used to calculate the saturating current
magnitude (Imax), half-maximal concentration (EC50) and
Hill coefficient (nH) values for glycine activation. Individual
concentration-response relationships were fitted using a
nonlinear least squares algorithm (SigmaPlot 11.0; Jandel
Scientific, San Rafael, CA, USA). Statistical analysis and
graphing were performed with SigmaPlot 11.0. Group data were
tested for normal probability distribution and for significant
differences between groups using one-way ANOVA. Pair-wise
comparisons were determined using Dunnett’s post hoc test,
where p< 0.05 was taken as the significance threshold.
Fluorescence-Based Imaging
Cells were imaged using an automated fluorescence-based
screening system using EYFPI152L fluorescence quench as an
indicator of anion influx. In this technique, iodide flowing
into the cell binds to and quenches EYFPI152L fluorescence,
thus providing an indication of the relative activity levels of
membrane anion channels (Kruger et al., 2005; Gilbert et al.,
2009). Briefly, HEK293 cells were transfected with the plasmid
DNAs for wild-type and mutant GlyR α4 constructs together
with a pEYFPI152L expression construct and plated into a
384-well plate. Unless otherwise indicated, all GlyR plasmid
DNAs were transfected in equimolar ratios. Within the following
24–32 h, the culture medium in the wells was replaced with
extracellular solution (140 mM NaCl, 5 mM KCl, 2 mM CaCl2,
1 mMMgCl2, 10 mM HEPES, and 10 mM glucose, pH 7.4 using
NaOH). After 30 min, fluorescence images of each well were
obtained twice, before and after the application of NaI solution
(140 mM NaI, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM
HEPES and 10 mM glucose, pH 7.4 using NaOH) containing
varying concentrations of glycine. Values were pooled from
three to four experiments with three wells each containing
>200 cells. To determine the glycine dose-response curve, an
empirical three or four parameter Hill equation was fitted by a
non-linear least squares algorithm using SigmaPlot 11.0 software.
Throughout this study, ‘‘% quench’’ is defined as the (initial
fluorescence − final fluorescence) × 100/initial fluorescence.
Thus, a treatment that completely abolished all fluorescence
would yield a 100% quench.
Immunolabeling and Imaging
Briefly, neuron-HEK293 cell co-cultures were fixed in 4%
paraformaldehyde for 15 min, washed with PBS and then
incubated in a blocking solution, containing 1% bovine serum
albumin in PBS, to minimize the background fluorescence
caused by non-specific antibody binding. The antibody-
containing solutions were diluted in the same blocking
solution. The cultures were first incubated overnight at
room temperature with GlyR-specific mouse monoclonal
mAb4a (Synaptic Systems, Germany), diluted 1:6250. After
washing with PBS, the cultures were incubated for 3 h
with 1:1000 donkey anti-mouse antibody and labeled with
Alexa-555 (ThermoFisher, Australia). After washing thoroughly
with PBS, cultures were incubated in a 1:6250 dilution of
mouse monoclonal primary antibody against the presynaptic
protein, synaptotagmin 1, labeled with Oyster 650 fluorophore
(Synaptic Systems, Germany). After overnight incubation,
cultures were washed with PBS, and coverslips mounted
onto glass slides using DABCO mounting solution prepared
as described (Johnson et al., 1982), sealed with acrylic and
stored at 4◦C.
Animal Care
Zebrafish were maintained and used for experiments in
accordance with the Norwegian Animal Protection Act
and with approval from Mattilsynet (the Norwegian
Food Safety Authority). Adults were reared at a maximal
density of five animals per liter at 28.5◦C in a 14/10
(light/dark) cycle environment. Fish were fed a mixture of
live artemia and TetraMin fish flakes twice a day. Larvae
were raised at 28.5◦C with a 14/10 day/night light cycle.
All experiments were performed at room temperature
on 1–3 days post fertilization (dpf) larvae unless stated
otherwise.
Zebrafish GlyR α4a Gene Trap Line
The zebrafish SAIGFF16B line was generated by the method
described in Kawakami et al. (2010) in which gene trap
vectors based on the Tol2 transposable element in combination
with the Gal4FF-UAS system were used. The gene trap
construct T2KSAIGFF contains the rabbit β-globin splice
acceptor (SA), followed by an internal ribosome entry site
(IRES), the coding region for Gal4FF (a modified version
of the yeast Gal4 transcription activator) and a downstream
polyadenylation site (pA). In zebrafish line SAIGFF16B, this
cassette is inserted between exons 1 and 2 of glra4a on
zebrafish chromosome 141. Gal4FF expression in SAIGFF16B
was visualized by creating double transgenic fish carrying a
Gal4FF transgene and the GFP reporter gene placed downstream
of the Gal4-recognition sequence (UAS:GFP) as previously
described.
Zebrafish GlyR α4a Knockdown and
α4aR278Q Mutant Expression
Specific antisense translation-blocking and splice-blocking
morpholinos (MOs) for GlyR α4a morpholinos (MOs) were
designed using alignments of exon 1 and exon 7 of zebrafish
GlyR genes and synthesized by GeneTools LLC. The morpholino
sequences used were: glra4aSMO1 5′-acctagaagagcacaaagagtttca-
3′, glra4aSMO2 5′-acaggaactcattttatgttacctt-3′, glra4aTBMO
5′-aaatccttatgacctgagggagcat-3′. We determined the optimal
MO amount required for induction of a specific phenotype
post-injection without inducing toxicity and off-target
effects. Glra4aTBMO was injected at 2 mM, glra4aSMO1
1http://kawakami.lab.nig.ac.jp/ztrap
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and glra4aSMO2 were injected at 1 mM. RT-PCR was also
used to examine splicing defects caused by glra4aSMO1
and glra4aSMO2 using poly(A) + RNA isolated at
72 hours post fertilization (hpf) using primers glra4aEx6F
5′-GCGGATGACTTGACTCTTCCTCAG-3′ and glra4aEx8R
5′-CCTTGAGACGAAGTTGACTGCTGCGTACTC-3′ using
primers for glra1 as controls: glra1Ex6F 5′-CTGAC
GTTACCTCAGTTTATATTG-3′ and glra1Ex8R 5′-GCG
CAGAAGCTCCTTGTGTTGGCG-3′. A dominant-negative
mutation p.R278Q in was introduced into a zebrafish GlyR α4a
subunit cDNA cloned into the pCS2 expression vector using the
QuikChange site directed mutagenesis technique, with primers
R278Q1 5′-ccacccagagctccggttcacaagcctcgctac-3′ and R278Q2
5′-gtagcgaggcttgtgaaccggagctctgggtgg-3′. In vitro transcribed
RNA for this construct was made with SP6 RNA polymerase and
microinjected into zebrafish embryos at a final concentration of
250 ng/ml.
RESULTS
GLRA4 Is a Pseudogene in the Human
Lineage, but Intact in Other Primates
To confirm that the human GlyR α4 subunit gene (GLRA4)
is transcribed and correctly spliced, we amplified full-length
cDNAs from human hippocampal and whole-brain first-strand
cDNA (Clontech) using proofreading Pfx DNA polymerase.
Sanger DNA sequencing of 10 human GlyR α4 subunit cDNAs
and comparison with the GLRA4 consensus sequence (hg38)
revealed that: (1) All cDNAs encoded a valine at position
57 (the more common variant of a known SNV; rs4907817,
C: 97.005%; T: 2.995%); (2) Two cDNA clones had the
change c.1345T >C, p.W421R, suggesting that this could be
a common polymorphism in human GLRA4. Importantly, all
ten cDNA clones contained an in-frame stop codon (TGA)
at position 390 in exon 9, truncating the GlyR α4 subunit
prematurely within the fourth membrane spanning domain
(M4). Despite this interruption, the coding region continues
intact, encoding the rest of M4 and a C-terminus with
high sequence identity to the corresponding sequence in
other species (Figures 1, 2). We found no evidence of RNA
editing of this stop codon, nor alternative splicing of GLRA4
transcripts that might restore a full reading frame. We also
analyzed the sequence of GLRA4 in a high-coverage genome
sequence of a Denisovan, an extinct relative of Neanderthals
(Reich et al., 2010). This analysis indicated the sequence
of the Denisova GlyR α4 subunit is identical to that of
modern day humans, including polymorphic reads at p.W421R,
suggesting that GLRA4 has been a pseudogene for at least
30,000–50,000 years.
The human GlyR α4 subunit consensus sequence was aligned
with equivalent proteins from primates and other vertebrates,
predicted from sequenced genomes accessed via Ensembl
release 87. Two alignments are shown in Figures 1, 2—an
alignment of human GlyR α4 subunit with orthologs from
ancient humans (Denisova) and different ape species, including
chimpanzee, gorilla, macaque, baboon and marmoset (Figure 1)
and human GlyR α4 subunit aligned with the mouse, rat
and zebrafish GlyR α4 subunits (Figure 2). This analysis
shows that GlyR α4 subunit sequences are most divergent
in the N-terminal signal peptide and the intracellular loop
between transmembrane domains M3 and M4. Outside these
regions, key differences between the human and Denisovan
GlyR α4 subunit and orthologs from ape species include:
(1) Extracellular domain: S55, K59, L145, K170, C204 (although
note that S55 and C204 are also found in chimpanzee and
gorilla sequences); (2) Transmembrane domain M3: I311; and
(3) C-terminal extracellular loop: W421. Notably, the stop
codon at position 390 is not present in any of the ape,
rodent or fish species, where either an arginine or glutamine is
found.
Functional Analysis of Recombinant
α4 GlyRs in HEK293 Cells
Initial functional screening was performed using a YFP-based
anion influx assay (Figure 3). Extracellular chloride was replaced
by iodide because iodide is a much more effective quencher
of YFP fluorescence (Kruger et al., 2005). Although the
relative permeability of iodide is about 2.3-fold greater than
that of chloride (Fatima-Shad and Barry, 1993), the single
channel conductance of GlyRs is not significantly changed
when chloride is replaced by iodide (Bormann et al., 1987).
As all the mutations investigated in this study are at a
considerable distance from the ion selectivity filter (Keramidas
et al., 2004) it is reasonable to assume that any difference
in relative anion permeability will not have any impact on
our results. Unless otherwise indicated, a saturating glycine
concentration (10 mM) was used in all experiments. Figure 1
shows sample images of HEK293 cells expressing YFP plus
the indicated GlyR constructs, taken before and after the
addition of 10 mM glycine. These experiments confirmed
that the wild-type human α4 GlyR, when recombinantly
expressed in HEK293 cells, does not form functional channels
(Figures 3A,B). Restoration of the arginine residue at X390 in
two independent constructs (X390R I and II) was insufficient
to restore human GlyR α4 subunit function. By contrast,
expression of artificially synthesized gorilla and chimp GlyR
α4 subunit cDNAs generated robust glycine-gated anion influxes
(Figures 3A,B), confirming that the GlyR α4 subunit is
functional in two species closely related to humans. Taken
together, these data suggest that the human GlyR α4 subunit
gene harbors further damaging changes compared to functional
mouse, gorilla and chimp GlyR α4 subunits. Outside the
variable M3-M4 loops, key differences between the human GlyR
α4 subunit and rat/mouse sequences include: (1) Signal peptide:
E3D, T8L/T8P; (2) Extracellular domain: S55G, I57V, K59E,
S80A, L145P, K170N, V174M, C204Y; (3) Transmembrane
domain M3: I311V; and (4) C-terminal extracellular loop:
W421R (Figure 2). Again, the X390 stop codon is not present
in either mouse or rat GlyR α4 subunits, where an arginine is
present.
We assessed the potentially damaging effects of these
changes in the GlyR α4 subunit using software packages SIFT
and PolyPhen-2. SIFT prediction is based on the degree of
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FIGURE 1 | Comparison of glycine receptor (GlyR) α4 subunit sequences in modern and ancient humans and selected primates. The position of the N-terminal
signal peptide is indicated by negative numbering, and potential cys-cys loops and membrane-spanning domains (M1–M4) are denoted by gray and blue boxes,
respectively. Residues in bold indicate key differences in aligned sequences, while those indicated in red type denote key changes in the human and Denisovan GlyR
α4 subunits compared with other primates (although note C204 is also found in gorilla and chimp GlyR α4). Residues in purple type indicate key determinants of the
GlyR agonist binding site.
conservation of amino acid residues in sequence alignments
derived from closely related sequences, collected through
PSI-BLAST (Kumar et al., 2009). PolyPhen-2 (Polymorphism
Phenotyping v2) is a tool that predicts possible impact of an
amino acid substitution on the structure and function of a
given protein using straightforward physical and comparative
considerations (Adzhubei et al., 2013). We used the mouse
GlyR α4 subunit as a starting point, since this subunit is
known to be functional in electrophysiological assays (Harvey
et al., 2000). The results are summarized in Table 1. While
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FIGURE 2 | Comparison of GlyR α4 subunit sequences in humans, rodents and zebrafish. The position of the N-terminal signal peptide is indicated by negative
numbering, and potential cys-cys loops and membrane-spanning domains (M1–M4) are denoted by gray and blue boxes, respectively. Residues in bold indicate key
differences in aligned sequences, while those indicated in blue and red type denote predicted non-damaging (blue) and damaging (red) changes in the human GlyR
α4 subunit compared with rodent GlyR α4 subunits predicted by bioinformatics analysis (Table 1). Residues in purple type indicate key determinants of the GlyR
agonist binding site.
most substitutions were tolerated/benign, E59K and R421W
were predicted to be not tolerated by SIFT, and E59K, P145L,
Y204C, V311I and R421W were predicted to be possibly or
probably damaging by PolyPhen-2. E59K results in a change
from a negatively-charged residue (E, glutamate) to a positively-
charged residue (K, lysine). R421W results in a change from
a positively-charged residue (R, arginine) to a large aromatic
residue (W, tryptophan). However, it is noteworthy that most
of the amino acids that are predicted to be damaging by
SIFT and PolyPhen-2 (K59, L145, I311, W421) are unique to
the human GlyR α4 subunit (Figures 1, 2). The exception is
C204, which introduces an additional reactive cysteine into
the ECD. GlyRs typically have five cysteine residues in the
ECD, four of which form disulfide bonds that are important
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FIGURE 3 | Functional analysis of α4 GlyRs using a fluorescence-based anion influx assay. (A) Sample images from HEK293 cells expressing YFP plus the human
α4 GlyR (left panel) or the gorilla α4 GlyR (right panel). Images were recorded in the presence of NaI bathing solution before and after a 10 s application of 10 mM
glycine. (B) Glycine concentration-response results for gorilla, chimpanzee and human GlyR α4 subunits. Two independent full-length human GlyR α4 subunit
expression constructs each containing the R390X stop codon were tested. The fluorescence change is plotted against the applied glycine concentration in
micromolar. All displayed data points represent the average quench from three experiments with three wells each and >200 cells per well. (C) Normalized maximal
changes in fluorescence observed upon the addition of NaI containing saturating (10 mM) glycine for the indicated potentially damaging mouse GlyR α4 mutants.
The maximal change in fluorescence is presented as the final (quenched) fluorescence value minus the initial fluorescence value. (D) Normalized maximal changes in
fluorescence observed upon the addition of NaI containing saturating glycine for the indicated potentially rescued human GlyR α4 subunit receptors. Mouse GlyR
α4 subunit represented in light gray, human GlyR α4 subunit mutants in dark gray. (E) Normalized maximal changes in fluorescence observed upon the addition of
NaI containing saturating glycine for wild-type human GlyR α4X390 subunits and human GlyR α4X390/K59E/C204Y mutant receptors. GlyR α1 (50%) means that only half
the amount of GlyR α1 was transfected, which represents the amount of GlyR α1 when the GlyR α4 subunit was co-transfected with α1. GlyR α1β (66%) represents
the corresponding heteromeric state. WT, wild-type GlyR α4X390; MT, mutant GlyR α4K59E/C204Y/X390. In (C–E), mutant values were normalized relative to the
wild-type value obtained from the same plate. p-values were calculated relative to mouse GlyR α4 and the human GlyR α1 using one-way ANOVA followed by
Dunnett’s post hoc test: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
for cell-surface expression and ECD folding (Vogel et al., 2009).
In the GlyR α1 subunit, these form a signature disulfide
loop (Cys138-Cys152) that is also found in nAChRs, 5HT3Rs
and GABAARs. In addition, a second GlyR-specific disulfide
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TABLE 1 | Prediction of potentially damaging changes in the human Inhibitory
glycine receptor (GlyR) α4 subunit compared to the mouse GlyR α4 subunit.
Change SIFT PolyPhen-2
D3E Tolerated Benign (score 0)
L8T Tolerated Benign (score 0.002)
G55S Tolerated Benign (score 0.003)
E59K Not tolerated (change in charge) Probably damaging (0.972)
A80S Tolerated Benign (score 0.046)
P145L Tolerated Possibly damaging (0.951)
N170K Tolerated Benign (score of 0.044)
M173V Tolerated Benign (score of 0)
Y204C Tolerated Probably damaging (0.993)
V311I Tolerated Possibly damaging (0.924)
M322I Tolerated Benign (score of 0)
R339Q Tolerated Benign (score of 0.01)
S366G Tolerated Benign (score of 0)
T374A Tolerated Benign (score of 0)
K378R Tolerated Benign (score of 0)
M383T Tolerated Benign (score of 0)
R390X - -
V408I Tolerated Benign (score of 0)
R421W Not tolerated (charge—bulky residue) Probably damaging (1)
Individual amino acid substitutions were made in the mouse GlyR
α4 subunit (Figure 2; Harvey et al., 2000) and potentially damaging
effects were assessed using SIFT (http://sift.jcvi.org/) and PolyPhen-2
(http://genetics.bwh.harvard.edu/pph2/).
bond is formed (Cys198-Cys209), leaving one cysteine (Cys41)
unpaired (Vogel et al., 2009). The equivalent residues in
the human GlyR α4 subunit are Cys144-Cys158, Cys205-Cys216
and Cys47. However, the human, chimp and gorilla GlyR
α4 subunits all contain an extra cysteine (Cys204) that
may have a significant impact on disulfide bond formation
(Figure 1).
To test the impact of the potentially damaging residues
in the human GlyR α4, we introduced G55S, E59K, P145L,
Y204C, V311I and R421W changes into the functional mouse
GlyR α4 subunit (Harvey et al., 2000). Upon functional
expression in HEK293 cells, we found that the E59K
substitution completely precluded functional expression,
whereas the Y204C change significantly reduced the maximal
change in fluorescence, suggesting either impaired receptor
trafficking, and/or receptor function (Figure 3C). The other
mutations had no deleterious effect (Figure 3C). To test
whether human GlyR α4 function could be restored by
reversing these mutations, residues in human GlyR α4 were
changed to the equivalent residues present in mouse GlyR
α4. Since E59K precluded functional expression in mouse
GlyR α4, we made the K89E change alone and together with
other potentially damaging mutations, K59E, K59E/C204Y,
K59E/W421R and K59E/C204Y/W421R, in both the truncated
(X390) and restored (R390) human GlyR α4 subunit. As
shown in Figure 3D, GlyR function could not be restored
by introducing K59E alone in either the GlyR α4X390 or
α4R390 backgrounds. However, introduction of K59E with
either C204Y or W421R restored function in the GlyR α4R390
background. This strongly suggests that multiple damaging
changes—in particular K59E and X390R, but also C204Y and
W421R—completely preclude function of the human GlyR
α4 subunit in vivo.
Since GlyRs truncated in theM3-M4 loop can be incorporated
into functional GlyRs when co-expressed with wild-type
GlyR subunits (e.g., the hyperekplexia mutation p.E375X,
Bode et al., 2013), we tested whether wild-type human GlyR
α4 subunits could act as negative regulators of other GlyR
subtypes, as proposed by Labonne et al. (2016). While wild-type
homomeric GlyR α1 and heteromeric α1β subunit GlyRs
generated robust glycine-induced fluorescence responses
(Figure 3E), the wild-type human GlyR α4 subunit harboring
the X390 truncating mutation (GlyR α4X390) was incapable
of forming functional homomeric or heteromeric GlyRs
(Figures 3B,E). Co-expression of human GlyR α1 and α4X390,
or α1, α4X390 and β subunits did not result in significant
changes in maximal fluorescence quench, suggesting that
co-expression of the native human GlyR α4X390 does not
influence function of homomeric α1 or heteromeric α1β
GlyRs (Figure 3E). An artificial mutant GlyR α4X390 subunit
that also incorporated the K59E and C204Y mutations
was also incapable of forming functional homomeric or
heteromeric GlyRs, but did reduce the observed maximal
fluorescence quench for when co-expressed with GlyR α1 or
α1β GlyRs (Figure 3E), suggesting that the artificial mutant
GlyR α4K59E/C204Y/X390 was incorporated into functional
pentamers.
We next sought to confirm the key results from Figure 3
via whole-cell electrophysiology in HEK293 cells. Examples
of current traces recorded in response to increasing glycine
concentrations for a subset of the investigated constructs are
shown in Figure 4A, with averaged concentration-response
relationships for all investigated constructs presented in
Figures 4B,C. First, glycine concentration-response relations
were determined for human α1 and mouse α4 GlyRs
(Figure 4B, Table 2). Their respective EC50 values were not
significantly different from each other. We next characterized
the human GlyR α4K59E/C204Y/X390R, α4K59E/X390R/W421R and
α4K59E/C204Y/X390 mutants. The glycine EC50 values for the
human α4K59E/C204Y/X390R and α4K59E/X390R/W421R GlyRs
were significantly reduced relative to those recorded for the
human α1 and mouse α4 GlyRs (Figures 4A,B, Table 2).
Although the truncated mutant α4K59E/C204Y/X390 GlyR was
non-functional when expressed alone, co-expression with the
wild-type human GlyR α1 subunit resulted in a significant
increase in glycine EC50 (from 64 ± 8 to 350 ± 29 µM,
p < 0.001; Figures 4A,B, Table 2) suggesting that the
truncated α4K59E/C204Y/X390 mutant can co-assemble with
human GlyR α1. However, restoration of two non-conserved
residues, E59K and Y204C, was required for co-assembly
and it is important to note that this artificial mutant does
not exist in vivo. Taken together, these data indicate that the
wild-type human α4X390 GlyR does not contribute to functional
GlyRs and cannot act as a negative regulator of other GlyR
subtypes.
Figure 3A also suggests that the gorilla and chimp α4 GlyRs
express strongly, despite incorporating Cys204 residues that
contribute to the impairment of the functional expression
of human α4 GlyRs. To confirm this, we quantified the
glycine concentration-response relationships of the mouse
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FIGURE 4 | Functional analysis of human, mouse and gorilla α4 subunit GlyRs using whole-cell patch-clamp electrophysiology. (A) Glycine dose-response sample
traces for truncated and full-length human α4K59E/C204Y GlyRs. The truncated form was co-expressed with the wild-type GlyR α1 subunit. Glycine dose-response
sample traces for wild-type mouse and gorilla α4 GlyRs are also shown. Filled bars indicate the applied glycine concentration in micromolar. (B) Normalized,
averaged glycine dose-response results for the indicated human GlyRs, together with wild-type mouse α4 subunit GlyRs for comparison. Parameters of best fit to
the Hill equation are summarized in Table 2. (C) Normalized, averaged glycine dose-response results for the indicated mouse and gorilla α4 subunit GlyRs.
Parameters of best fit to the Hill equation are summarized in Table 2.
α4 and α4β GlyRs and the gorilla α4 and α4β GlyRs. When
expressing heteromeric GlyRs, we transfected α4 and β
subunits at a ratio of 1:100 given that has been shown to
maximize the expression of heteromeric GlyRs in HEK293 cells
(Zhang Y. et al., 2015). Examples of currents recorded in
response to increasing glycine concentration for the mouse
and gorilla homomeric GlyRs are shown in Figure 4A,
with averaged results for homomeric and heteromeric
GlyRs presented in Figure 4C and Table 2. There was no
significant difference in EC50 values among the four receptors,
TABLE 2 | Properties of GlyRs measured using whole-cell patch-clamp electrophysiology.
GlyR construct EC50 (µM) nH Imax (nA) n
Human α1 41 ± 6 2.7 ± 0.3 2.9 ± 0.3 6
Human α4K59E/X390R/W421R 7.6 ± 1.3∗ 2.2 ± 0.1 2.3 ± 0.5 5
Human α4K59E/C204Y/X390R 4.3 ± 1.3∗ 2.1 ± 0.3 2.8 ± 0.5 5
Human α4K59E/C204Y + α1 350 ± 29∗∗∗ 3.1 ± 0.4 3.9 ± 0.6 4
Mouse α4 61 ± 10 1.6 ± 0.1 2.8 ± 0.6 9
Mouse α4β 45 ± 13 1.8 ± 0.1 3.8 ± 0.5 8
Gorilla α4 86 ± 16 1.8 ± 0.1 1.7 ± 0.7 5
Gorilla α4β 71 ± 13 1.7 ± 0.2 0.9 ± 0.2 9
EC50 values, Hill coefficients (nH) and the maximal currents (Imax ) are represented. p-values were calculated relative to α1 subunit GlyRs using one-way ANOVA followed
by Dunnett’s post hoc test: ∗p < 0.05, ∗∗∗p < 0.0001.
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indicating no deleterious effect of the gorilla α4 GlyR Cys204
residue.
Properties of IPSCs Mediated by Mouse
and Gorilla α4β GlyRs in Artificial Synapses
Whole-cell recordings from transfected HEK293 cells in
co-culture with spinal neurons regularly exhibited robust,
spontaneous IPSCs mediated by mouse α4 and α4β GlyRs and
gorilla α4 and α4β GlyRs (Figure 5A). Figure 5B shows digitally
averaged and normalized IPSCs from single HEK293 cells
expressing mouse and gorilla α4β GlyRs, together with a control
IPSC mediated by α1β GlyRs. Mean IPSC 10%–90% rise times,
decay time constants and amplitudes, presented in Figures 5C–E,
reveal no significant differences among the four α4-subunit
containing GlyRs. However, it is evident from Figure 5B that
IPSCs mediated by α4β GlyRs exhibit dramatically slower decays
than those mediated by α1β GlyRs. Indeed, the mean decay time
constant of IPSCs mediated by α4-containing GlyRs (∼80 ms;
Figure 5C) is drastically slower than those mediated by either
α1β, α2β or α3β GlyRs (7.2, 25.7 and 9.7 ms, respectively;
Zhang Y. et al., 2015).
To investigate the mechanism responsible for the slow IPSC
decay, we first sought to determine whether α4β GlyRs were
located in clusters apposed to presynaptic terminals in artificial
synapses. We employed immunofluorescence to compare the
degree to which mouse α4 and α4β GlyRs co-localized with
synaptotagmin, a presynaptic marker. Sample images of single
co-cultured HEK293 cells transfected with α4 and α4β GlyRs,
respectively, are shown in Figure 5F. The percentage overlap
between synaptotagmin and GlyR immunofluorescence was
36± 13% (n = 4 cells) for α4 GlyRs and 69± 5% (n = 7 cells) for
α4βGlyRs. The difference was significant (p< 0.02 by ANOVA),
indicating that α4β GlyRs exhibit more pronounced clustering.
This is expected given that β subunits mediate GlyR anchoring to
the synapse via a direct interaction with gephyrin (Meyer et al.,
1995), which are both recombinantly expressed in our artificial
synapse system.
To determine whether the IPSC decay rate was determined
by the intrinsic receptor closing rate, we recorded ensemble
currents from outside-out patches excised from HEK293 cells
that expressed either mouse α4 or α4β GlyRs. To mimic synaptic
activation conditions, we applied a saturating (3 mM) glycine
concentration for 1 ms via a piezoelectric translation device.
Examples of ensemble currents activated under these conditions
for the two isoforms are shown in Figure 6A with the mean
deactivation time constants and 10%–90% rise times (averaged
from 6 patches each) summarized in Figures 6B,C. A two-way
ANOVA revealed no statistically significant difference in rise
times. However, the mean decay time constant for α4 GlyRs
(661 ± 103 ms) was significantly slower than that for α4β
GlyRs (354 ± 48 ms; p < 0.05 by ANOVA). These decay
times are substantially slower than those for α1 and α1β GlyRs
recorded under similar conditions. Homomeric α1 subunit
GlyRs decay with a time constant of 24 ms (Scott et al.,
2015), whereas heteromeric α1β subunit GlyRs decay with
time constants that range from 16 ms (Scott et al., 2015)
FIGURE 5 | Properties of spontaneous inhibitory postsynaptic currents
(IPSCs) recorded from artificial synapses incorporating mouse α4, mouse α4β,
gorilla α4 and gorilla α4β GlyRs. (A) Representative recordings of IPSCs from
HEK293 cells expressing each isoform at two temporal scales. (B) Averaged
(from 20 to 100 events), normalized IPSCs from individual cells expressing
mouse α4 and α4β GlyRs. A corresponding waveform from a human α1β GlyR
is also shown. (C–E) Mean IPSC decay time constants, 10%–90% rise times
and amplitudes. n values ranged from 5 to 12. Means were tested for
significance using one-way ANOVA although no statistically significant
differences were found. (F) Images of HEK293 cells that receive artificial
synaptic contacts from co-cultured spinal neurons. Images in the top and
bottom rows are from the same cells that were transfected with mouse α4 and
α4β GlyRs, respectively. Immunolabeling for synaptotagmin (green), GlyR (red)
and overlay (yellow) are shown for each cell. Scale bars = 5 µm.
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FIGURE 6 | Outside-out macropatch recordings of currents mediated by mouse α4 and α4β GlyRs. (A) Sample recordings from macropatches expressing the
indicated isoforms in response to ≤1 ms applications of saturating (3 mM) glycine. Patches were clamped at −70 mV and 15–40 sweeps were averaged from each
recorded patch. (B) Mean deactivation time constants reveal a significant difference between the two isoforms (∗p = 0.02, n = 6 patches for both). (C) Mean
10%–90% activation times reveal no significant difference between isoforms.
to 26 ms (Zhang et al., 2016). Thus, the deactivation time
constant for the α4β GlyR is an order of magnitude slower
than for the α1β GlyR. Moreover, we observed that, as for
α1 subunit GlyRs, currents mediated by α4-containing GlyRs
exhibit faster decay times when expressed at synapses. For
instance, α1β and α4β GlyR currents decay ∼3–4-fold faster at
synapses compared to macropatch recordings, likely reflecting
the presence of intracellular modulatory factors that shape IPSCs
that are removed upon macropatch excision.
A Zebrafish Gene Trap Line Reveals glra4a
Expression in Brainstem and Spinal Cord
Neurones
In order to learn more about the biological role of GlyR
α4 we turned to zebrafish, which have two GlyR α4 subunit
genes (glra4a and glra4b) with distinct expression patterns
(Imboden et al., 2001; Hirata et al., 2010; Hensley et al.,
2011). In 24 hpf embryos, glra4b (previously known as αZ4)
expression was previously reported to be restricted to the
rhombencephalic portion of the midbrain-hindbrain boundary
and the rhombic lip, but from 52 hpf was confined to the
retina (Imboden et al., 2001; Hensley et al., 2011). By contrast,
glra4a (previously known as αZ2) was reported to be more
widely expressed in the olfactory pits, the mesencephalon, the
rhombencephalon and the somites (Imboden et al., 2001).
In this study, we used a novel Tol2 based gene-trap line
(Kawakami et al., 2010), to map the expression of glra4a in
more detail. The zebrafish line SAIGFF16B contains a reporter
cassette integrated into glra4a between exon 1 and exon 2.
This cassette encodes the yeast transcription factor activator
protein GAL4, flanked by IRES and a polyadenylation signal
(Figure 7A). GAL4 works efficiently as a transcription factor
when it binds to an upstream activator sequence (UAS) located
near a fluorescent protein such as enhanced green fluorescent
protein (EGFP). The zebrafish glra4a:GAL4 gene-trap line was
therefore crossed with a UAS:EGFP line. The offspring express
GAL4, which binds to the UAS and subsequently triggers the
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FIGURE 7 | A novel zebrafish glra4a gene trap reveals expression in the zebrafish brain and spinal cord. (A) The zebrafish SAIGFF16B line contains the gene trap
construct T2KSAGFF inserted between exons 1 and 2 of glra4a. This cassette contains a splice acceptor (SA), followed by an internal ribosome entry site (IRES), the
coding region for the Gal4FF transcription activator and a polyadenylation site (pA). Gal4FF expression in SAIGFF16B was visualized by creating double transgenic
fish carrying the Gal4FF transgene and a GFP reporter gene placed downstream of the Gal4-recognition sequence (UAS:GFP). (B,C) GFP expression in the glra4a
gene-trap line at 48 hours post fertilization (hpf) reveals that glra4a is predominantly expressed four clusters of hindbrain commissural neurons and selected spinal
commissural interneurons. (D) High magnification dorsal view of neurons indicated by arrows in (C). (E,F) Images show a portion of the zebrafish spinal cord at
48 hpf (E) and 72 hpf (F) showing glra4a expression in commissural primary (CoPA, white arrows) and secondary (CoSA, orange arrows). Scale bars: (B): 500 µm;
(C); 250 µm; (D): 150 µm; (E,F): 50 µm.
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FIGURE 8 | Morpholino oligonucleotides (SMO1 and SMO2) block splicing of glra4a. (A) Gross morphology of wild-type embryos and those injected with GlyR α4a
translation-blocking (TMO) or splice site (SMO1 and SMO2) morpholinos. (B) Schematic of RT-PCR analysis of glra4a morpholinos confirmed the deletion of exon
7 for α4a-SMO1 (lane 3) and the deletion of part of exon 7 for α4a-SMO2 (lane 4). Intact GlyR α4a exon 7–9 PCR products are seen in the control (393 bp, lane 2)
and smaller amounts are also observed in lanes 3 and 4. A fragment of around 178 bp is seen in SMO1, which is made up of exon 6 and 8 only. A fragment of
321 bp in SMO2 contains exons 6 and 8 and part of exon 7, which excludes the region that codes for TM2. GlyR α1 exon 7 is present in control and both SMO fish
(lower panel). (C,D) DNA sequencing of GlyR α4a cDNAs from SMO1 and SMO2 treated fish reveals that SMO1 results in a 215 bp deletion, resulting in a frameshift
and premature stop codon before M1, while SMO2 results in a 72 bp deletion and loss of 24 amino acids, including the majority of the pore-forming M2 domain.
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production of EGFP. Therefore, areas within the zebrafish where
EGFP is detected indicate cells where glra4a:GAL4 is normally
expressed. EGFP expression directed by glra4a:GAL4 at 48 hpf
revealed that glra4awas predominantly expressed four clusters of
hindbrain commissural neurons and selected spinal commissural
interneurons (Figures 7B–D). The expression of glra4a:GAL4 in
commissural primary and secondary ascending neurons of the
spinal cord increased in intensity from 48 hpf to 72 hpf
(Figures 7E,F). These spinal commissural neurones had two
distinct morphologies: large soma with multidendritic processes
and small soma with few dendrites. Interestingly, no motor
neurons or other types of interneurons were labeled in this line.
Morpholino Knockdown and
Overexpression of an Artificial GlyR α4a
R278Q Mutation Reveals Aberrant
Swimming Behavior
Splice site (SMO) and translation blocking (TMO) morpholinos
α4a-SMO1, α4a-SMO2 and α4a-TMO were injected into
zebrafish embryos. The morphology of the injected zebrafish was
assessed at 48 hpf (Figure 8A) and did not reveal any gross
anatomical changes apart from slightly smaller eyes that were
apparent in embryos injected with α4a-TMO and α4a-SMO1
(Figure 8A). Although it was not possible to monitor the
efficacy of α4a-TMO knockdown, due to the lack of a specific
GlyR α4a subunit antibody, RT-PCR was used to monitor the
effects of α4a-SMO1 and α4a-SMO2. mRNA was extracted
from zebrafish that had been injected with α4a-SMO1 and α4a-
SMO2 plus non-injected zebrafish embryos (wild-type control).
RT-PCR was performed using primers targeted within exon 6
(forward) and exon 8 (reverse) of zebrafish glra4a and the PCR
products corresponding to exons 6–8 analyzed by agarose gel
electrophoresis and DNA sequencing (Figure 8B). This analysis
suggested that binding of α4a-SMO1 to the splice acceptor site
resulted in skipping of exon 7 in a proportion of transcripts
(note lower 178 bp band), whilst binding of α4a-SMO2 to the
exon 7 acceptor site resulted in mis-splicing, so that a different
‘‘acceptor’’ site was used within exon 7. DNA sequencing of GlyR
α4a cDNAs from SMO1 and SMO2 treated fish revealed that
SMO1 indeed resulted in exon 7 skipping (a 215 bp deletion)
resulting in a frameshift and premature stop codon before M1.
SMO2 results in usage of an exonic donor site, resulting in a 72 bp
deletion and loss of 24 amino acids, including the majority of
the pore-forming M2 domain (Figure 8C). By contrast, RT-PCR
with similar primers targeted against zebrafish glra1 did not
result in any aberrant splicing (Figure 8B, lower right panel)
suggesting that the GlyR α4amorpholinos used did not recognize
this closely related target.
Wild-type zebrafish embryos respond to tactile stimulus
with an ‘‘escape response’’ consisting of a C-bend, a counter-
turn, and a bout of rapid swimming (Figure 9A). However,
FIGURE 9 | Embryos injected with α4a-SMO1 and the α4aR278Q mutant embryos fail to exhibit correct escape behavior. (A) Wild-type (control) fish responds to
touch by with a C-bend, a turn away from the stimulus and rapid swimming. However, embryos injected with α4a-SMO1 (B) or with mRNA for the GlyR α4aR278Q
subunit (C) respond more slowly, and have a pronounced head retraction—similar to a localized beo-like contraction (arrow). Single images were extracted from
high-speed movies of α4a-SMO1 morphants and embryos injected with GlyR α4aR278Q subunit mRNA.
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behavioral analysis of zebrafish embryos injected with α4a-
SMO1 gave rise to transient spasms and prolonged head
retraction (Figure 9B). α4a-SMO1 morphants did eventually
recover and swim away from the stimulus, although this
took longer than for wild-type zebrafish (Figures 9A,B).
Thus, knockdown with α4a-SMO1 significantly impaired escape
behavior. The same behavior was observed in embryos injected
with in vitro-transcribed RNA for a GlyR α4a subunit mutant
harboring the R278Qmutation (Figure 9C; GlyR α4aR278Q). This
mutation is equivalent to the dominantly inherited startle disease
mutation p.R271Q in the human GlyR α1 subunit (Shiang et al.,
1993) that disrupts the link between agonist binding and channel
gating without affecting cell-surface trafficking (Langosch et al.,
1994; Chung et al., 2010). This suggests that the GlyR α4aR278Q
dominant-negative mutant is able to incorporate into native
zebrafish GlyRs and alter behavior in the same manner as
morpholino knockdown by α4a-SMO1, resulting in aberrant
tactile startle and escape responses.
DISCUSSION
The known biological roles of inhibitory GlyRs have expanded
significantly in recent years, in part due to the range of
mouse/zebrafish mutants and subtype-specific antibodies now
available (Harvey et al., 2004; Hirata et al., 2010; Pilorge et al.,
2016; Wilkins et al., 2016; Schaefer et al., 2017). However, GlyRs
containing the α4 subunit have largely escaped scrutiny, largely
because the human gene has an in-frame stop codon in exon
9, truncating the GlyR α4 subunit in the M4 domain. The GlyR
α4 subunit gene is clearly intact and expressed in other organisms
(e.g., Matzenbach et al., 1994; Harvey et al., 2000) and is even
duplicated (GlyR α4a and α4b) in zebrafish (Imboden et al.,
2001; Hirata et al., 2010). Given the recent implication of the
human GlyR α4 subunit gene in human disease, we sought to:
(1) Determine whether the human GlyR α4 subunit is indeed
functional or can act in a dominant-negative manner; (2) To
characterize the functional properties of α4-subunit GlyRs in
artificial synapses; and (3) Determine the biological role of GlyR
α4 using zebrafish as a model organism.
The Human GlyR α4 Subunit Is Functionally
Inactive Due to Multiple Damaging
Changes
Cloning and sequencing of human GlyR α4 subunit cDNAs
(Figures 1, 2) demonstrated that GLRA4 is still transcribed
and correctly spliced in human brain. However, no alternative
splicing or RNA editing was observed that could ‘‘correct’’ the
stop codon found at position 390. Functional expression of
‘‘wild-type’’ human GlyR α4X390 did not result in functional
GlyRs, although artificially-synthesized gorilla and chimpanzee
α4 subunit cDNAs could direct the formation of functional
GlyRs (Figure 3A). It was therefore surprising that mutagenesis
of the stop codon in human GlyR α4 to a conserved arginine
(p.X390R) did not restore function. Bioinformatics analysis using
SIFT and PolyPhen-2 and further mutagenesis of the mouse
and human GlyR α4 subunit cDNAs (Figures 3B,C) revealed
that the human GlyR α4 subunit contains multiple damaging
changes—including K59E and X390R, and to a lesser extent
C204Y and W421R—that inactivate human GlyR α4 subunit
function. Restoration of multiple amino acids (K59E with either
C204Y or W421R) was required to restore function in the
GlyR α4R390 background. It is curious that either C204Y or
W421R had an equivalent effect in restoring function given
that: (1) these residues are not located near each other; and
(2) incorporation of either residue together with K59E and
X390R results in α4 GlyRs with very high glycine sensitivity
(EC50s: α4K59E/X390R/W421R: 7.6 ± 1.3 µM; α4K59E/C204Y/X390R:
4.3 ± 1.3 µM; Table 2). The similarly high glycine sensitivities
of the human α4K59E/C204Y/X390R and α4K59E/X390R/W421R GlyRs
are presumably caused by other residues that are not conserved
between human and other species (e.g., L145, K170, I311). This
finding also indicates that the individual C204 or W421 human
residues do not completely impair GlyR function, which is
supported by our mouse GlyR α4 mutagenesis study (Figure 3B)
and the fact that we observed no deleterious effect of the gorilla
GlyR α4 Cys204 residue in whole-cell patch-clamp experiments
that compared mouse α4 and α4β GlyRs with gorilla α4 and
α4β GlyRs (Figure 4). This in turn rules out the possibility that
the loss of function in the α4K59E/X390R GlyR is a cumulative
effect of the two mildly ‘‘deleterious’’ endogenous residues
(i.e., C204 and W421). Lastly, we also found that ‘‘wild-type’’
GlyR α4X390 subunit was unable to act as a negative regulator
of other GlyR subtypes (Figures 3D, 4). This was at first
surprising, given that several elegant studies (Villmann et al.,
2009; Haeger et al., 2010) have shown that truncated proteins
containing the N-terminal ligand-binding domain and first three
transmembrane helices (M1–M3) of the GlyR α1 subunit can
be rescued by co-expressing the fourth transmembrane domain
(M4). However, additional artificial restoration of K59E/C204Y
was required before co-assembly with the GlyR α1 subunit
was observed. Hence, we consider it highly unlikely that the
endogenous GlyR α4 subunit is involved in human disease by the
mechanisms proposed by Labonne et al. (2016). Rather, sequence
analysis of high coverage reads from the Denisovan genome
(Reich et al., 2010) suggest that GLRA4 has been a pseudogene
for at least 30,000–50,000 years.
Unique Functional Properties of α4 Subunit
GlyRs Revealed in Artificial Synapses and
Outside-Out Patches
Until this study, the functional properties of IPSCs mediated by
α4-containing GlyRs had not been determined for any species.
We therefore made whole-cell recordings from HEK293 cells
expressing mouse or gorilla α4 and α4β GlyRs along with
neuroligin 2 that had been co-cultured with spinal neurons. In
this system, expression of GlyR α1–3 homomers typically results
in robust IPSCs, with GlyR β subunit incorporation accelerating
IPSC rise and decay times for α2β and α3β heteromers. In
addition, α1β and α3β GlyRs mediate fast decaying IPSCs,
whereas α2β GlyRs mediate slow decaying IPSCs (Zhang Y.
et al., 2015). In this study, we show that analysis of IPSCs
(Figure 5) and analysis of IPSC 10%–90% rise times, decay time
constants and amplitudes, revealed no significant differences
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between homomeric α4 and heteromeric α4β-subunit mouse
and gorilla GlyRs (Figure 5). IPSCs mediated by α4 or α4β
GlyRs had a dramatically slower mean decay time constant
(∼80 ms; Figure 5C) than those mediated by either α1β, α2β
or α3β GlyRs (7.2, 25.7 and 9.7 ms, respectively; Zhang Y.
et al., 2015). Another unusual finding was that the intrinsic
closing rate of the mouse α4 and α4β GlyRs in outside-out
patches excised from HEK293 cells (Figure 6B) was much
slower than the corresponding IPSC decay rate (Figure 5B).
One possible explanation is that the synaptic clustering process
imposes a conformational change upon α4-containing GlyRs
that induces them to close at a faster rate. We were surprised
to find that the α4β GlyR deactivation time constant was an
order of magnitude slower than for the α1β GlyR (Scott et al.,
2015; Zhang et al., 2016). We are not aware of any other
pentameric ligand-gated ion channel that deactivates at such a
slow rate. Taken together, these findings suggest that α4 subunit-
containing GlyRs have a unique physiological function and
are possibly more suited to tonic rather than fast synaptic
signaling.
A Biological Role for GlyR α4 in Startle and
Escape Responses
In order to develop an in vivo model of GlyR α4 dysfunction,
we utilized zebrafish, where an extended GlyR gene family (α1,
α2, α3, α4a, α4b, βa and βb) presents many advantages for the
study of receptor biology (Hirata et al., 2010, 2013; Ganser et al.,
2013; Pilorge et al., 2016). Zebrafish also present other benefits
in terms of the availability of artificial mutants and techniques
for gene manipulation. For example, zebrafish bandoneon
(beo) mutants harbor missense or nonsense mutations in glrbb
that cause compromised glycinergic transmission and touch-
induced bilateral muscle contractions (Hirata et al., 2005; Ganser
et al., 2013). We have also previously demonstrated that GlyR
gene-specific morpholinos can reveal distinct phenotypes in
zebrafish larvae, such as embryonic spasticity (GlyR α1; Ganser
et al., 2013) and axon-branching defects (GlyR α2; Pilorge et al.,
2016). Zebrafish contain two GlyR α4 subunit genes, glra4a
and glra4b, with the expression of the latter gene being largely
restricted to the retina (Imboden et al., 2001; Hensley et al., 2011).
Using a novel Tol2-based gene-trap line, we detected glra4a
expression in small interneuron populations in the hindbrain
and commissural primary and secondary ascending neurons of
the spinal cord (Figure 7). We tested and validated multiple
splice-site and translation blockingmorpholinos (MOs) targeting
glra4a using RT-PCR and DNA sequencing to show exon
skipping and alternate acceptor site usage for exon 7 MOs
resulting in truncation of zebrafish GlyR α4a (Figure 8).
High-speed video analysis of zebrafish embryos injected with
α4a splice site morpholino (SMO1) or a dominant-negative
GlyR α4aR278Q subunit mutant gave rise to transient spasms and
prolonged head retraction after a tactile stimulus (Figure 9).
Thus, glra4a knockdown in zebrafish results in aberrant tactile
escape responses, suggesting that at least in fish, GlyR α4a helps
to shape startle and escape responses. Given the known role of the
spinal GlyR α1β subtype in startle disease in humans and animal
models (Shiang et al., 1993; Ganser et al., 2013; Wilkins et al.,
2016; Schaefer et al., 2017), a role for GlyR α4 in escape behaviors
is not unexpected. However, one obvious area for future study is
whether loss of GlyR α4 in humans has resulted in key differences
in terms of startle and/or escape responses compared to other
species.
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